Treatment
Treatment clinical trials
We’re tracking 8,557 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07087405Recruiting
Deep skin abrasion for stretch marks
This trial tests a treatment called deep skin abrasion for stretch marks. It may help improve the appearance of stretch marks by gently sanding the top layers of skin.
Boston, MassachusettsAges 18–70 - NCT06969742Recruiting
Mental health program for young cancer survivors and caregivers
This trial tests a program to help improve mental health and quality of life for teenagers and young adults who have had a solid tumor cancer, and for their caregivers. It focuses on those recently finished treatment or still in treatment, and aims to provide supportive counseling.
Goyang-si, Gyonggi-doAges 10–24 - NCT06931639Recruiting
Suicide prevention therapy for teens
This trial tests a talking therapy designed to prevent suicide in teens. It helps young people and their caregivers work together after a recent suicide attempt.
HelsingborgAges 10–17 - NCT06840782RecruitingPhase 3
Immunotherapy plus local treatments for early spread lung cancer
This trial tests whether adding local treatments like radiation or surgery to standard immunotherapy can help people with lung cancer that has spread to a few spots. It aims to see if this combination improves control of the disease.
Creil, Hauts-de-FranceAges 18 years+ - NCT06793956RecruitingPhase 1
Testing sintilimab and linperlisib for NK/T-cell lymphoma
This trial tests a combination of two drugs, sintilimab (immunotherapy) and linperlisib (targeted therapy), for people whose NK/T-cell lymphoma has come back or did not respond to previous treatment. The goal is to see if this combination can help shrink or control the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT06273137Recruiting
Positive affect treatment for teens with early adversity
This trial tests a treatment designed to improve positive emotions in adolescents who have experienced stressful early life events. It may help your teen build resilience and emotional wellbeing.
Irvine, CaliforniaAges 12–16 - NCT06278870RecruitingPhase 3
New drug combo vs standard for HER2+ advanced breast cancer
This trial compares two drug combinations for HER2-positive breast cancer that has spread. It tests a newer drug (Disitamab Vedotin + Pyrotinib) against a standard treatment (THP) as a first treatment option.
Guangzhou, GuangdongAges 18–75 - NCT06195228RecruitingPhase 4
Real-world study of genetic types in advanced thyroid cancer
This study looks at how different genetic types of advanced thyroid cancer respond to treatment in real-world settings. It may help doctors choose the best therapy for you based on your tumor’s genetic makeup.
Fuzhou, FujianAges Any age - NCT06323837RecruitingPhase 2
Testing mirtazapine for methamphetamine use in people on opioid treatment
This trial tests whether the antidepressant mirtazapine can help reduce methamphetamine use in people who are already receiving medication for opioid use disorder. It aims to see if adding this medication improves outcomes for those struggling with both conditions.
Spokane, WashingtonAges 18 years+ - NCT06037473Recruiting
PEG growth hormone for short stature in children
This trial tests if a long-acting growth hormone (PEGylated GH) helps children with various causes of short stature grow taller. It may be an option if your child has a condition like growth hormone deficiency, Turner syndrome, or idiopathic short stature.
Beijing, Beijing MunicipalityAges Up to 18 years - NCT06080620Recruiting
Choosing the best treatment for locally advanced breast cancer
This study looks at different treatment plans for women with newly diagnosed, locally advanced breast cancer (stage IIIb-IIIc). It aims to find the most effective combination of surgery, chemotherapy, and radiotherapy. If you are a woman aged 18-70 with this diagnosis and your tumor can be surgically removed, this trial may be an option for you.
BeijingAges 18–70 - NCT06067165Recruiting
Online emotion-regulation program for teens
This trial tests an online program called POET that helps teens learn skills to manage emotions. The program includes a parent part, so a guardian will also be involved. It may be a good option if you are between 12 and 17, have mild to moderate mental health struggles, and are not already in another treatment.
StockholmAges 12–17 - NCT06029374Recruiting
Comparing treatments for hand bone fractures
This trial compares two treatments for a common hand fracture—the boxer's fracture—to see if one is better. It will help people recover quickly without surgery.
ViennaAges 18–70 - NCT05965622Recruiting
Cost-effectiveness of ABFT for youth with suicidality
This study looks at whether ABFT (a family-based therapy) works well and is worth the cost for young adults who have strong suicidal thoughts. It also uses your family’s involvement to see how treatment affects safety and well-being over time.
Tongeren, LimburgAges 18–25 - NCT05882591Recruiting
Treating a specific inner-knee cartilage and meniscus problem
This trial looks at a treatment for a specific knee alignment and tissue problem inside the inner (medial) part of your knee. It may help people whose deep-squat knee pain is caused by rubbing (“impingement”) between the femur and the back part of the medial meniscus.
Bełchatów, Łódź VoivodeshipAges 18–70 - NCT05640453RecruitingPhase 4
Testing pregabalin or dexmedetomidine for post-surgery delirium
This study compares two medicines—pregabalin and dexmedetomidine—to treat confusion (called delirium) after heart bypass surgery. It aims to see which drug works better to reduce delirium symptoms in older adults after coronary artery bypass surgery.
Tanta, El-Gharbia GovernorateAges 65 years+ - NCT05754372Recruiting
Dialysis-focused treatment study for newborn high ammonia
This trial looks at how to best treat newborns with very high ammonia in the blood when urgent dialysis is needed. It may help doctors choose the most effective way to rapidly lower ammonia and improve outcomes in babies with certain inherited metabolic conditions.
GhentAges Up to 1 year - NCT05520892RecruitingPhase 4
IVIG dose options for newly diagnosed childhood ITP
This study compares two intravenous (IV) IgG treatment regimens for children newly diagnosed with immune thrombocytopenia (ITP). It aims to find a regimen that works well and is safe for raising low platelet counts.
Fuzhou, FujianAges 4 weeks–14 years - NCT05292404RecruitingPhase 4
PCSK9 medicine soon after heart attack to protect the heart
This trial studies whether starting a PCSK9-blocking medicine early after a specific type of heart attack can improve heart outcomes. You may be eligible if you have a STEMI heart attack soon, are planning a procedure to open the blocked artery, and meet safety and pregnancy criteria.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07037264Enrolling by invitation
Laser treatment for thyroid surgery scars
This study tests if a special laser can improve scars from thyroid surgery. It is for people with fresh or older scars in the middle of the neck.
Beijing, Beijing MunicipalityAges 18–70 - NCT05454046Recruiting
Food intake study during fertility treatment
This study looks at what women and men eat during common fertility treatments. The goal is to understand whether food patterns may relate to fertility treatment outcomes, which could help improve future guidance.
AalborgAges Any age - NCT05563012RecruitingPhase 2
Short radiation plus chemo and PD-1 immunotherapy for stomach cancer
This Phase 2 trial tests whether giving a short course of radiation before surgery, along with chemotherapy and a PD-1 immunotherapy drug, can improve treatment outcomes for locally advanced stomach cancer. It may help shrink the tumor before surgery and strengthen the immune system’s attack on cancer.
Wuhan, HubeiAges 18–75 - NCT05597540RecruitingPhase 3
Shorter antibiotics for kidney transplant kidney infections
This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.
BordeauxAges 18 years+ - NCT05280132Recruiting
Testing quick tests to shorten antibiotics in severe COPD flare
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
ParisAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,557 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.